PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAdams Respiratory Therapeutics
Adams Respiratory Therapeutics(ARXT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Erdosteine
healthy volunteers/patients
,
infections
,
acquired immunodeficiency syndrome
,
communicable diseases
,
hiv infections
,
chronic bronchitis
,
bronchitis
,
fatty liver
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
hiv-1
Lotamilast
non-hodgkin lymphoma
,
healthy volunteers/patients
,
b-cell lymphoma marginal zone
,
b-cell lymphoma
,
breast neoplasms
,
carcinoma
,
renal cell carcinoma
,
endometrial neoplasms
,
cytomegalovirus infections
,
sensorineural hearing loss
,
lymphoma
,
follicular lymphoma
Remetinostat
healthy volunteers/patients
,
agnosia
,
pain
,
bone fractures
,
acute pain
Tiratricol
infections
,
communicable diseases
,
respiratory tract infections
,
common cold
Usistapide
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
parkinson disease
,
respiratory tract infections
,
infections
,
communicable diseases
,
drug-related side effects and adverse reactions
,
kidney transplantation
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use